You are here

cell therapies

ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients

BioSpace

Wed, 04/13/22 - 10:44 am

Allogene, broadening its reach, helps start a new biotech in China

BioPharma Dive

Tue, 12/15/20 - 10:47 am

Overland Pharmaceuticals

Allogene Overland Pharma

AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients

Xconomy

Thu, 07/30/20 - 11:20 pm

organ transplant

Bayer-backed Century buys Empirica to create brain cancer CAR-Ts

Fierce Biotech

Tue, 06/23/20 - 11:01 am

Century Therapeutics

Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020

BioPharma Dive

Fri, 06/5/20 - 11:02 am

J&J inks Fate deal to move into allogeneic CAR therapies

Fierce Biotech

Fri, 04/3/20 - 12:29 pm

Fate Therapeutics

drug development

GSK pays $50M for 2 solid tumor cell therapies from Immatics

Pharmaceutical Business Review

Thu, 02/20/20 - 10:23 am

Myeloma cell therapies, now in pharma hands, move into spotlight

Biopharma Dive

Sat, 12/7/19 - 11:47 pm

Multiple Myeloma

Bristol-Myers Squibb

Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight

Xconomy

Wed, 08/28/19 - 10:55 am

drug development

Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments

Yahoo/Reuters

Tue, 07/30/19 - 07:51 am

Biotech’s newborn unicorn Sana grabs Harvard tech aimed at slipping engineered stem cells past the immune system

Endpoints

Tue, 03/26/19 - 11:13 pm

Sana Biotechnology

Pluristem’s cell therapies head for orbit with NASA deal

Fierce Biotech

Wed, 02/20/19 - 10:12 am

Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes

Drug Delivery Business News

Wed, 04/4/18 - 09:08 am

drug development

type 1 diabetes